Since the Federal Circuit’s October 5, 2017 decision in Amgen Inc. v. Sanofi overruling the so-called “newly characterized antigen”...
About the PTAB
-
-
Making up only around 7% of post-grant trials at the PTAB (according to statistics released by the USPTO from February 2018), the number of...
-
On Thursday, March 15, 2018, Commissioner for Patents, Andrew Hirshfeld, announced that the USPTO is making progress on its “Access to...
-
Section 315(c) of the America Invents Act (“AIA”) provides that if the Director of the U.S. Patent and Trademark Office...
-
The United States Patent and Trademark Office (USPTO) published new and updated guidelines on subject matter eligibility on February 5,...
-
Posted in:
USPTO Trims the Regulatory Fat
On Friday, January 19, 2018, in a Federal Register notice, the USPTO identified four regulations that it is proposing to abolish. The...
-
Seven new IPRs were filed against patents held by Alacritech Inc. on December 27, 2017. These IPRs (four of which were filed by Dell and...